Technology
BioQuadrant has established core expertise in the design and chemical synthesis of a number of attractive, novel intermediates for the drug discovery process. Our new entities are mostly based on the incorporation of conformational constraints into molecules in order to increase receptor selectivity of the ligands these new molecules are incorporated into (peptidomimetics, peptides, small molecules).
Our technology's portfolio consist of: